Novità nel mondo di Medicina di Laboratorio
The Week That Wasn't: Cold Cure, Sickle Cell, Polluted Placenta
Three medical stories that we didn't cover, explained.
Medscape
Medscape
Categorie: Novità nel mondo di Medicina di Laboratorio
IUD Use Linked to Reduced Risk of Ovarian Cancer
Women who use an intrauterine device for contraception have a reduced risk of getting ovarian cancer, according to a new meta-analysis of existing retrospective data.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Can Video Gaming Trigger Dangerous Arrhythmias?
Ventricular arrhythmias are typically exacerbated by physical exercise, but a new case series suggests even sedentary activities may increase the risk in children with certain conditions.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Novel TAVR Approach Dramatically Cuts Need for Pacemaker
TAVR carries risk of postprocedure pacemaker implantation. A new technique using the patient's individual anatomy to determine device location may decrease this complication, a new study suggests.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Hypertension Linked to Cognitive Decline, but Treatment Helps
In a large Chinese population study, the treatment of hypertension was linked to a slower progression of cognitive decline.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
EAN Guidelines Endorse Early Palliative Care Dialogue in MS
Both specialists and general practitioners caring for people with severe MS and their families should discuss palliative care options in advance, new guidelines emphasize.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
New Data on Natalizumab During Pregnancy in MS
Women with multiple sclerosis who continued to receive the drug during pregnancy had a much lower risk of relapses, according to a new Italian observational study.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Point-of-Care Testing Useful for Newborn Sickle Cell Screening
Point-of-care testing is useful for newborn screening for sickle cell disease (SCD) in low-income settings, according to results from an observational study.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio
Recommended TSH Norm for Patients on Thyroxine Shows No Ill Effect
Recommended "normal" thyroid-stimulating hormone (TSH) concentrations for hypothyroid patients receiving thyroxine are not associated with increased risk of cardiovascular disease, fractures, or all-cause mortality, according to new findings.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio
Blood Lipid Changes at Age 8 in Kids Genetically Prone to Diabetes
Children who have a high genetic risk score for adult type 2 diabetes also appear to have lower levels of HDL, or 'good' cholesterol, as early as age 8.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Reimagining STI Clinics for a New Generation
Clinics that are designed to be stylish, easy to access, and efficient are changing the way cities tackle STI testing and treatment.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
What Do You Think About Hospital Data Partnerships With Big Tech?
Under a new 10-year partnership, the Mayo Clinic will store patient data with Google Cloud and use the tech giant's technology to develop new healthcare tools.
Medscape Reader Polls
Medscape Reader Polls
Categorie: Novità nel mondo di Medicina di Laboratorio
Retinopathy Associated With Topical Oral Corticosteroid Use
Central serous retinopathy has been reported following systemic corticosteroid use. Might a topical corticosteroid used for dental treatment be the cause of this patient's central serous retinopathy?
Journal of Medical Case Reports
Journal of Medical Case Reports
Categorie: Novità nel mondo di Medicina di Laboratorio
Small Prolonged Reductions in LDL, BP Substantially Reduce CV Risk
A new Mendelian randomization study shows the large benefits that could be achieved from small reductions in cholesterol and blood pressure if maintained over a lifetime.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
US, Canada, Australia Approve Endometrial Cancer Combo
Regulatory agencies in three countries, including the United States, all approved lenvatinib in combination with pembrolizumab for the treatment of patients with advanced endometrial carcinoma.
FDA Approvals
FDA Approvals
Categorie: Novità nel mondo di Medicina di Laboratorio
USPSTF Finds Evidence Insufficient for Routine MCI Screening
Should asymptomatic older adults be screened for incipient dementia? No, according to this draft recommendation released by the USPSTF.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Race, Income May Impact U.S. Oral Cancer Screening Rates
Only about 1 in 3 U.S. adults say a dentist has ever examined them for oral cancer - and most of those who remember getting such exams are non-Hispanic whites, a new study suggests.
Reuters Health Information
Reuters Health Information
Categorie: Novità nel mondo di Medicina di Laboratorio
Underserved Communities Receive Hep C Treatment in Jail
The testing and treatment of inmates for hepatitis C can be effective, but system efficiencies, perceptions, and limits on care after release can present obstacles.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Obesity Poses Much Bigger Risk for Diabetes Than Bad Genes
The study highlights the dominance of obesity as a risk factor for type 2 diabetes and reinforces the "importance of weight management in diabetes prevention...in all genetic risk groups," say researchers.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio
Ofatumumab Impresses in MS; Competition for Ocrelizumab Soon?
A new B cell-depleting therapy, given as a monthly subcutaneous injection, has shown impressive results in two phase 3 studies in relapse-remitting multiple sclerosis.
Medscape Medical News
Medscape Medical News
Categorie: Novità nel mondo di Medicina di Laboratorio